"skipMainNavigation"
Search
Quick Search in Journals
Quick Search anywhere
Advanced Search
Radiology
Menu
Previous
Next
Original Research

Extrapulmonary Malignancies Detected at Lung Cancer Screening

Published Online:Oct 1 2011https://doi.org/10.1148/radiol.11102231

Abstract

Our results suggest that a considerable number of unsuspected extrapulmonary malignancies can be detected in a lung cancer screening setting; careful evaluation of extrapulmonary structures, with particular attention to the kidneys and lymph nodes, is recommended.

Purpose

To retrospectively assess the detection rate, histologic characteristics, and clinical stage of screening-detected extrapulmonary malignancies in a population at high risk for lung cancer.

Materials and Methods

In this institutional review board–approved study, 5201 asymptomatic heavy smokers aged 50 years or older underwent annual low-dose computed tomography (CT) for 5 consecutive years. The 5-year cumulative effective dose was 5 mSv. Subjects with at least one “potentially significant extrapulmonary incidental finding” (PS-IF) were extracted from the study database. An extrapulmonary finding was classified as potentially significant if it required further diagnostic and/or clinical evaluation. In retrospect all clinically relevant information, including findings from diagnostic work-up and final diagnosis of the PS-IF, was collected. On the basis of the information collected, only histologically proved screening-detected extrapulmonary malignancies were eventually included in this study. The percentages of volunteers with extrapulmonary malignancies were calculated, along with 95% confidence intervals (CIs), on the basis of a binomial distribution.

Results

After 5 years of CT screening, 27 unsuspected extrapulmonary malignancies were diagnosed, representing 0.5% (27 of 5201 subjects; 95% CI: 0.34%, 0.75%) of volunteers enrolled and 6.2% (27 of 436 findings; 95% CI: 4.12%, 8.88%) of PS-IFs. Eight malignancies were diagnosed at the 1st year of screening, nine at the 2nd year, four at the 3rd year, two at the 4th year, and four at the 5th year. Twelve of the 27 extrapulmonary tumors (44%) were renal carcinomas (n = 7) or lymphomas (n = 5). Twenty-four of the 27 subjects with a malignancy were alive at the most recent follow-up.

Conclusion

A considerable number of unsuspected extrapulmonary malignancies can be detected in lung cancer screening trials. A careful evaluation of extrapulmonary structures, with particular attention to the kidneys and lymph nodes, is recommended.

© RSNA, 2011

References

  • 1 Ferlay J, Bray F, Pisani P, et al.. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. Lyon, France: IARC Press, 2004.
    Google Scholar
  • 2 Janssen-Heijnen ML, Coebergh JW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 2001;31(2-3):123–137.
    Medline Google Scholar
  • 3 Berrino R, Capocaccia R, Esteve J, et al.. Survival of cancer patients in Europe: the EUROCARE-2 study. IARC Scientific Publication No.151. Lyon, France: World Health Organization, International Agency for Research on Cancer, European Commission, 1999.
    Google Scholar
  • 4 Henschke CI, McCauley DI, Yankelevitz DF, et al.. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354(9173):99–105.
    Medline Google Scholar
  • 5 Sone S, Takashima S, Li F, et al.. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998;351(9111):1242–1245.
    Medline Google Scholar
  • 6 Diederich S, Lenzen H, Puskas Z, et al.. Low dose computerized tomography of the thorax: experimental and clinical studies. [in German]. Radiologe 1996;36(6):475–482.
    Medline Google Scholar
  • 7 Swensen SJ, Jett JR, Hartman TE, et al.. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003;226(3):756–761.
    Google Scholar
  • 8 MacRedmond R, Logan PM, Lee M, Kenny D, Foley C, Costello RW. Screening for lung cancer using low dose CT scanning. Thorax 2004;59(3):237–241.
    Medline Google Scholar
  • 9 van de Wiel JC, Wang Y, Xu DM, et al.. Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT. Eur Radiol 2007;17(6):1474–1482.
    Medline Google Scholar
  • 10 Veronesi G, Bellomi M, Mulshine JL, et al.. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer 2008;61(3):340–349.
    Medline Google Scholar
  • 11 Veronesi G, Bellomi M, Scanagatta P, et al.. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg 2008;136(3):611–617.
    Medline Google Scholar
  • 12 Berland LL, Silverman SG, Gore RM, et al.. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 2010;7(10):754–773.
    Medline Google Scholar
  • 13 Pickhardt PJ, Kim DH, Meiners RJ, et al.. Colorectal and extracolonic cancers detected at screening CT colonography in 10 286 asymptomatic adults. Radiology 2010;255(1):83–88.
    Google Scholar
  • 14 Humphrey LL, Johnson M, Teutsch S. Lung Cancer Screening: an update for the U.S. Preventive Services Task Force. Rockville, Md: Agency for Healthcare Research and Quality (US). http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=es31. Published May 2004. Accessed October 2010.
    Google Scholar

Article History

Received November 11, 2010; revision requested February 3, 2011; revision received April 29; accepted May 25; final version accepted June 3.
Published online: Oct 2011
Published in print: Oct 2011